Cabio Biotech Wuhan Co Ltd (688089) - Total Liabilities

Latest as of September 2025: CN¥183.42 Million CNY ≈ $26.84 Million USD

Based on the latest financial reports, Cabio Biotech Wuhan Co Ltd (688089) has total liabilities worth CN¥183.42 Million CNY (≈ $26.84 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cabio Biotech Wuhan Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Cabio Biotech Wuhan Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Cabio Biotech Wuhan Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Cabio Biotech Wuhan Co Ltd Competitors by Total Liabilities

The table below lists competitors of Cabio Biotech Wuhan Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sky Harbour Group Corp NYSE MKT:SKYH	USA	$357.28 Million
Dah San Electric Wire & Cable Co Ltd TW:1615	Taiwan	NT$1.81 Billion
Satin Creditcare Network Limited NSE:SATIN	India	Rs115.19 Billion
Marine Products Corporation NYSE:MPX	USA	$31.14 Million
Anton Oilfield Services Group F:5AO	Germany	€7.83 Billion
Ser Educacional Sa SA:SEER3	Brazil	R$1.96 Billion
Jouder Precision Industry Kunshan Co Ltd SHE:300549	China	CN¥175.28 Million
Globus Spirits Limited NSE:GLOBUSSPR	India	Rs11.59 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Cabio Biotech Wuhan Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Cabio Biotech Wuhan Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cabio Biotech Wuhan Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cabio Biotech Wuhan Co Ltd (2013–2024)

The table below shows the annual total liabilities of Cabio Biotech Wuhan Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥117.27 Million ≈ $17.16 Million	-0.28%
2023-12-31	CN¥117.60 Million ≈ $17.21 Million	-36.69%
2022-12-31	CN¥185.77 Million ≈ $27.18 Million	+178.61%
2021-12-31	CN¥66.68 Million ≈ $9.76 Million	+12.44%
2020-12-31	CN¥59.30 Million ≈ $8.68 Million	+22.89%
2019-12-31	CN¥48.26 Million ≈ $7.06 Million	-12.25%
2018-12-31	CN¥54.99 Million ≈ $8.05 Million	+31.01%
2017-12-31	CN¥41.98 Million ≈ $6.14 Million	-43.41%
2016-12-31	CN¥74.17 Million ≈ $10.85 Million	-13.35%
2015-12-31	CN¥85.60 Million ≈ $12.53 Million	+106.19%
2014-12-31	CN¥41.52 Million ≈ $6.08 Million	+4.62%
2013-12-31	CN¥39.68 Million ≈ $5.81 Million	--

About Cabio Biotech Wuhan Co Ltd

SHG:688089 China Biotechnology

Market Cap

$280.03 Million

CN¥1.91 Billion CNY

Market Cap Rank

#15250 Global

#4494 in China

Share Price

CN¥11.37

Change (1 day)

-0.96%

52-Week Range

CN¥11.37 - CN¥29.99

All Time High

CN¥48.06